Mylan Recalls Levetiracetam Tablets Due to Foreign Tablet Presence
Mylan Pharmaceuticals is recalling 960 bottles of Levetiracetam 500 mg tablets because foreign tablets may have been distributed in the bottles.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury/property-damage reports or high-risk scenarios.
Plain-English summary
Mylan Pharmaceuticals Inc. is recalling 960 bottles of Levetiracetam Tablets, USP 500 mg. The recall was initiated because the manufacturer may have distributed foreign tablets in bottles of the medication.
The affected product is identified by Lot ZLMM12063 with an expiration date of March 2014. The product was distributed to Kentucky. This is a prescription-only medication manufactured for Mylan Pharmaceuticals Inc. in Morgantown, WV.
Consumers who have this specific lot of Levetiracetam should stop using it and contact their healthcare provider or pharmacist for guidance on how to dispose of the product or obtain a replacement.
The recalled product
- Product
- LEVETIRACETAM (LEVETIRACETAM)
- Brand
- LEVETIRACETAM
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot ZLMM12063
- Exp March 2014
Distribution
Distributed in 1 state:
Related recalls
Same brand · LEVETIRACETAM
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateAurobindo Recalls Levetiracetam Tablets Due to Manufacturing Water Leakage
FDA (Drugs) · 2020-04-22
- SevereDr. Reddy's Recalls Levetiracetam Injection Due to Labeling Error
FDA (Drugs) · 2019-02-20
- SevereAuroMedics Recalls Levetiracetam Injection Due to Sterility Concerns
FDA (Drugs) · 2018-05-09
- SevereAuroMedics Recalls Levetiracetam Injection Due to Sterility Concerns
FDA (Drugs) · 2018-05-09
Same manufacturer · Mylan Pharmaceuticals Inc.
See all →- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- HighMycophenolate Mofetil Injection Recalled Due to Precipitate in Vials
FDA (Drugs) · 2026-08-05
- HighAmnesteem isotretinoin 40 mg capsules failed dissolution specifications
FDA (Drugs) · 2026-03-11
- HighPrasugrel 5 mg Tablets Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2025-03-26
- CriticalInsulin Glargine Prefilled Pens Recalled for Missing Label
FDA (Drugs) · 2022-08-03
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02